Business
You can’t rely on the S&P 500 as much as you may think
By Katherine Langford
Lilly raises outlook for third time this year as Zepbound sales soar
Katherine Langford
Katherine Langford
Editor-in-Chief · Edina, MN
Katherine oversees editorial operations across all six brands. Before joining The Meridan Group, she spent 14 years at the Minneapolis Star Tribune, where she led the metro desk through its digital transformation. She holds a Master's in Journalism from Northwestern's Medill School.
More from Katherine →Editor-in-Chief · Thursday, October 29, 2026 at 11:19 AM · 1 min read
The GLP-1 drug continues to dominate the market for prescription weight-loss drugs in the U.S.
Up nextYou can’t rely on the S&P 500 as much as you may thinkBusiness · 1 min read
More Business stories
Business
The Fed held off on a rate hike. Today’s GDP and inflation reports could make waiting harder.
By Katherine Langford
Business
‘There may be better investment options’: My church received $1.5 million from a parishioner. Is 3.75% interest enough?
By Katherine Langford
Business
The major reason Microsoft’s stock is heading higher after earnings
By Katherine Langford